ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NEJM Paper: Ownership of IMRT Centers Prompts Urologists to Refer Patients to Radiation Therapy

October 25, 2013

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

New Guidelines Developed For Cooperative Group Grant Review

August 17, 1979

DCT Board Approves Concept of New Programs, Including “Task Order”

November 2, 1979

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979